Skip to main content
SpringerLink
Log in

Current concepts and recent advances in the management of age-related macular degeneration

  • original paper
  • Published:
Irish Journal of Medical Science Aims and scope Submit manuscript

Abstract

Background Age-related macular degeneration (AMD) is the leading cause of visual impairment and blindness in the Western World in those aged 65 and older.1 At present, several treatment modalities are utilised and several more are undergoing investigation in an attempt to retard the occurrence and progression of this devastating condition.

Aims To provide the non-ophthalmologist with an understanding of the current treatment options available to patients suffering from all variants of AMD.

Methods Medline and Embase search.

Results Several treatment modalities have been investigated and utilised in the treatment of all variants of this condition. While promising results have been reported, no treatment is ideal.

Conclusion While no curative treatment for this condition currently exists, early recognition and treatment, if indicated, have been shown to reduce the risk of severe vision loss in patients with this condition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lowenstein A, Bressler NM, Bressler SB. Epidemiology of RPE disease. In: Marmor MF, Wolfensberger TJ, eds. Retinal pigment epithelium: current aspects of function and disease. New York: Oxford University Press, 2000.

    Google Scholar 

  2. Kahn HA, Leibowitz HM, Ganley JP et al. The Framingham Eye Study. I. Outline and major prevalence findings.Am J Epidemiol 1977; 106: 17–32.

    PubMed  CAS  Google Scholar 

  3. Bressler NM, Bressler SB, West SK et al. The grading and prevalence of macular degeneration in Chesapeake Bay watermen.Arch Ophthalmol 1989; 107: 847–52.

    PubMed  CAS  Google Scholar 

  4. Klein R, Klein BEK, Linton KLP. Prevalence of age-related maculopathy. The Beaver Dam Eye Study.Ophthalmology 1992; 99: 933- 43.

    PubMed  CAS  Google Scholar 

  5. Mitchell P, Smith W, Attebo K et al. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study.Ophthalmology 1995; 102: 1450–60.

    PubMed  CAS  Google Scholar 

  6. Vingerling JR, Dielemans I, Hofman A et al. The prevalence of age-related maculopathy in the Rotterdam Study.Ophthalmology 1987; 94: 1191–5.

    Google Scholar 

  7. Pizzarello LD. The dimensions of the problem of eye disease among the elderly.Ophthalmology 1987; 94: 1191–5.

    PubMed  CAS  Google Scholar 

  8. Evans J, Wormland R. Is the incidence of registrable age-related macular degeneration increasing?Br J Ophthalmol 1996; 80: 9–14.

    Article  PubMed  CAS  Google Scholar 

  9. Pagenstecher H, Genth CP. Atlas der pathologischen Anatomie des Augenapfels. Wiesbaden, Kriedel CW, 1875.

    Google Scholar 

  10. Bird AC, Bressler NM, Bressler SB et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group.Surv Ophthalmol 1995; 39: 367–74.

    Article  PubMed  CAS  Google Scholar 

  11. Age-Related Eye Disease Study Research Group. A Randomised, Placebo- Controlled Clinical Trial of High-Dose Supplementation Vitamin C and E, Beta-carotene, and Zinc for Age-Related Macular Degeneration.Arch Ophthalmol 2001; 119: 1417–36.

    Google Scholar 

  12. Fllesler SJ, Anderson RE. Chemistry and metabolism of lipids in the vertebrate retina.Prog Lipid Res 1983; 22: 79–131.

    Article  Google Scholar 

  13. Gerster H. Review: antioxidant protection of the ageing macula.Age Ageing. 1991; 112: 60–9.

    Article  Google Scholar 

  14. Young RW. Solar radiation and age-related macular degeneration.Surv Ophthalmol. 1998; 32: 252–69.

    Article  Google Scholar 

  15. Beatty S, Koh H, Phil M, Henson D, Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration.Surv Ophthalmol 2000; 45: 115–34.

    Article  PubMed  CAS  Google Scholar 

  16. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study G roup. The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers.N Eng J Med 1994; 330; 1029- 35.

    Article  Google Scholar 

  17. Dietary antioxidant intake and incidence of early age-related maculopathy — The Blue Mountains Eye Study. Flood V, Smith W, Wang JJ, Manzi F, Webb K, Mitchell P.Ophthalmology 2002; 109(12): 2272–78.

  18. Gass JDM. Pathogenesis of disciform detachment of the n€epithelium.Am J Ophthalmol 1967; 63: 617–64.

    Google Scholar 

  19. Green WR, Key SN. Senile macular degeneration: a histopathologic study.Trans Am Ophthalmol Soc 1977; 75: 80–254.

    Google Scholar 

  20. Ferris III FL, Fine SL, Hyman L. Age-related macular degeneration and blindness due to neovascular maculopathy.Arch Ophthalmol 198; 102: 1640–42.

  21. Coscas G, Glaser B, Green WR et al. Dégénerescences maculaires liées a 1’âge néovaisseaux rétiniens. Paris: Masson, 1991: 447.

    Google Scholar 

  22. Macular Photocoagulation Study Group. Visual outcome after laser photocoagulation for subfoveal choroidal neovascularization secondary to age-related macular degeneration. The influence of initial lesion size and initial visual acuity.Arch Ophthalmol 1994; 112: 480–88.

    Google Scholar 

  23. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration. Updated findings from two clinical trials.Arch Ophthalmol 1993; 111: 1200–09.

    Google Scholar 

  24. Macular Photocoagulation Study Group. Laser photocoagulation for juxtafoveal choroidal neovascularisation. Five-year results from randomized clinical trials.A rch Ophthalmol 1994; 112: 500–09.

    Google Scholar 

  25. Freund KB, Yannuzzi LA, Sorenson JA. Age-related macular degeneration and choroidal neovascularisation.Am J Ophthalmol 1993; 115: 786–91.

    PubMed  CAS  Google Scholar 

  26. Grey RHB, Bird AC, Chisholm M. Senile disciform macular degeneration: features indicating suitability for photocoagulation.Br J Ophthalmol 1979; 63: 85–9.

    Article  PubMed  CAS  Google Scholar 

  27. Scheider A, Gundisch O, Kampik A. Surgical extraction of subfoveal choroidal new vessels and submacular haemorrhage in age-related macular degeneration: results of a prospective study.Graefes Arch Clin Exp Ophthalmol 1999; 237: 10–15.

    Article  PubMed  CAS  Google Scholar 

  28. Ciulla TA, Danis RP, Harris A. Age-related macular degeneration: a review of experimental treatments.Surv Ophthalmol 1998; 43: 134–46.

    Article  PubMed  CAS  Google Scholar 

  29. Thomas MA, Dickinson JD, Melberg NS et al. Visual results after surgical removal of subfoveal choroidal neovascular membranes.Ophthalmology 1994; 101: 1384–96.

    PubMed  CAS  Google Scholar 

  30. Algvere PV, Berglin L, Gouras P, Sheng Y. Transplantation of foetal retinal pigment epithelium in age-related macular degeneration with subfoveal neovascularisation.Graefes Arch Clin Exp Ophthalmol 1994; 232: 707–16.

    Article  PubMed  CAS  Google Scholar 

  31. Submacular Surgery Trials. Submacular surgery trials randomised pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularisation secondary to age-related macular degeneration. I. Ophthalmic outcomes: Submacular surgery trials pilot study report number 1(2).Am J Ophthalmol 2000; 130: 387–407.

    Article  Google Scholar 

  32. Eckardt C, Eckardt U, Conrad HG. Macular rotation with and without counter- rotation of the globe in patients with age-related macular degeneration.Graefes Arch Clin Exp Ophthalmol 1999; 237: 313–25.

    Article  PubMed  CAS  Google Scholar 

  33. Lewis H, Kaiser PK, Lewis S, Estafanous M. Macular translocation for subfoveal choroidal neovascularisation in age-related macular degeneration: a prospective study.Am J Ophthalmol 1999; 128: 135- 46.

    Article  PubMed  CAS  Google Scholar 

  34. Machemer R, Steinhorst UH. Retinal separation, retinotomy, and macular relocation: II. A surgical approach for age-related macular degeneration?Graefes Arch Clin Exp Ophthalmol 1993; 231: 635–41.

    Article  PubMed  CAS  Google Scholar 

  35. Wolf S, Lappas A, Weinberger AWA et al. Macular translocation for surgical management of subfoveal choroidal neovascularisations in patients with AMD: first results.Graefes Arch Clin Exp Ophthalmol 1999; 237: 51–7.

    Article  PubMed  CAS  Google Scholar 

  36. Merrill PT, LO Russo FJ, Lomeo MD et al. Surgical removal of subfoveal choroidal neovascularisation in age-related macular degeneration.Ophthalmology 1999; 106: 782–89.

    Article  PubMed  CAS  Google Scholar 

  37. Kychenthal A, Stanga PE, Fitke FW et al. Retinal pigment epithelium translocation after choroidal neovascular membrane removal in agerelated macular degeneration.Invest Ophthalmol Vis Sci 1999; 40: S207.

    Google Scholar 

  38. Manyak MJ, Russo A, Smith PD et al. Photodynamic therapy.J Clin Oncol 1988; 6: 380–91.

    PubMed  CAS  Google Scholar 

  39. Hussain D, Miller JW. Photodynamic therapy for age-related macular degeneration.Sem Ophthalmol 1997; 12: 14–25.

    Article  Google Scholar 

  40. Husain D, Miller JW, Michaud N et al. Intravenous infusion of liposomal benzoporhyrin derivative for photodynamic therapy of experimental choroidal neovascularisation.Arch Ophthalmol 1996; 114: 978–85.

    PubMed  CAS  Google Scholar 

  41. Schmidt-Erfurth U, Bimgruber R, Hasan T. Photodynamic therapy in ocular vascular disease.Laser Physics 1998; 8: 191–8.

    CAS  Google Scholar 

  42. Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularisation in age-related macular degeneration with verteporfin. Two-year results of 2 randomised clinical trials: TAP report 2.Arch Ophthalmol 2001; 119: 198–207.

    Google Scholar 

  43. Sharma S, Brown GC, Brown MM, Hollands H, Shah GK. The cost effectiveness of photodynamic therapy for fellow eyes with subfoveal choroidal neovascularisation secondary to age-related macular degeneration.Ophthalmology 2001; 108: 11: 2051–59.

    Article  PubMed  CAS  Google Scholar 

  44. The Royal College of Ophthalmologists. Photodynamic Therapy for Subfoveal Choroidal Neovascularisation. Focus Issue 17. Spring 2001.

  45. Sharma S, Hollands H, Brown GC, Brown MM, Shah GK, Sharma SM. Improvement in quality of life from photodynamic therapy: a Canadian perspective.Can J Ophthalmol 2001; 36(6): 332–8.

    PubMed  CAS  Google Scholar 

  46. Newsom RSB, Me Alister JC, Saeed M, Me Hugh JDA. Transpupillary thermotherapy for the treatment of choroidal neovascularisation.Br J Ophthalmol 2001; 85: 173–8.

    Article  PubMed  CAS  Google Scholar 

  47. Sherr DL, Finger PT. Radiation therapy for age-related macular degeneration.Sem Ophthalmol 1997; 12: 26–33.

    Article  Google Scholar 

  48. Arlett C, Harcourt F. Survey of radiosensitivity in a variety of human cell strains.Cancer Res 1980; 40: 926–32.

    PubMed  CAS  Google Scholar 

  49. Rheinhold HS, Buisman GH. Radiosensitivity of capillary endothelium.Br J Radiol 1973; 46: 54–7.

    Google Scholar 

  50. Archer DB, Amoaku WMK, Gardiner TA. Radiation Retinopathy:clinical, histological and ultrastructural correlation.Eye 1991; 5: 239–51.

    PubMed  Google Scholar 

  51. Chakravarthy U. Radiotherapy for choroidal neovascularisation of agerelated macular degeneration: a fresh perspective.Eye 2000; 14: 151–4.

    PubMed  Google Scholar 

  52. Marcus DM, Sheils W, Johnson MH, Mc Intosh SB, Leibach DM, Magire A et al. External beam irradiation of subfoveal choroidal neovascularisation complicating age-related macular degeneration. One year results of prospective, double masked, randomised clinical trial.Arch Ophthalmol 2001; 119: 275–6.

    Google Scholar 

  53. Spaide RF, Guyer DR, McCormick B, Yannuzzi LA, Burke K, Mendelsohn M et al. External beam radiation therapy for choroidal neovascularisation.Ophthalmology 1998; 105: 24–30.

    Article  PubMed  CAS  Google Scholar 

  54. D’Amato RJ, Loughnan MS, Flynn E et al. Thalidomide is an inhibitor of angiogenesis.Proc Natl Acad Sci USA 1994; 91: 4082–5.

    Article  PubMed  CAS  Google Scholar 

  55. Kenyon BM, Browne F, D’Amato RJ. Effects of thalidomide and related metabolites in a mouse corneal model of neovascularisation.Exp Eye Res 1997; 64: 971–8.

    Article  PubMed  CAS  Google Scholar 

  56. Ciulla TA, Danis RP, Harris A. Age-related macular degeneration: a review of experimental treatments.Surv Ophthalmol 1998; 43: 134–46.

    Article  PubMed  CAS  Google Scholar 

  57. Lanchoney DM, Maguire MG, Fine Sl. A model of the incidence and consequences of choroidal neovascularisation secondary to age-related neovascularisation: comparative effects of current treatment and potential prophylaxis on visual outcomes in high-risk patients.Arch Ophthalmol 1998; 116: 1045–52.

    PubMed  CAS  Google Scholar 

  58. Choroidal Neovascularisation Prevention Trial Research Group. Laser treatment in eyes with large drusen: short-term effects seen in a pilot randomised clinical trial.Ophthalmology 1998; 105: 11–23.

    Article  Google Scholar 

  59. Choroidal Neovascularisation Prevention Trial Research Group. Laser-Induced drusen reduction improves visual function at 1 year.Ophthalmology 1999; 106: 1367–73.

    Google Scholar 

  60. Olk RJ, Friberg TR, Stickney KL et al. Therapeutic benefits of infrared (810nm) diode laser macular grid photocoagulation in prophylactic treatment of non-exudative age-related macular degeneration: two year results of a randomised pilot study.Ophthalmology 1999; 106: 1082–2090.

    Article  Google Scholar 

  61. Wright AF. Gene therapy for the eye.Br J Ophthalmol. 1997; 81: 620–63.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Royal Victoria Infirmary, Newcastle-upon-Tyne, UK

    S Byrne

  2. Department of Ophthalmology, Waterford Regional Hospital, Ireland

    S Beatty

Authors
  1. S Byrne
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S Beatty
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S Byrne.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Byrne, S., Beatty, S. Current concepts and recent advances in the management of age-related macular degeneration. Ir J Med Sci 172, 185–190 (2003). https://doi.org/10.1007/BF02915287

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02915287

Keywords

Search

Navigation